Literature DB >> 10861092

Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex.

K Fujio1, Y Misaki, K Setoguchi, S Morita, K Kawahata, I Kato, T Nosaka, K Yamamoto, T Kitamura.   

Abstract

Transfer of the alphabeta TCR genes into T lymphocytes will provide a means to enhance Ag-specific immunity by increasing the frequency of tumor- or pathogen-specific T lymphocytes. We generated an efficient alphabeta TCR gene transfer system using two independent monocistronic retrovirus vectors harboring either of the class II MHC-restricted alpha or beta TCR genes specific for chicken OVA. The system enabled us to express the clonotypic TCR in 44% of the CD4+ T cells. The transduced cells showed a remarkable response to OVA323-339 peptide in the in vitro culture system, and the response to the Ag was comparable with those of the T lymphocytes derived from transgenic mice harboring OVA-specific TCR. Adoptive transfer of the TCR-transduced cells in mice induced the Ag-specific delayed-type hypersensitivity in response to OVA323-339 challenge. These results indicate that alphabeta TCR gene transfer into peripheral T lymphocytes can reconstitute Ag-specific immunity. We here propose that this method provides a basis for a new approach to manipulation of immune reactions and immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861092     DOI: 10.4049/jimmunol.165.1.528

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells.

Authors:  Lili Yang; Xiao-Feng Qin; David Baltimore; Luk Van Parijs
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 2.  Exploiting T cell receptor genes for cancer immunotherapy.

Authors:  S Xue; R Gillmore; A Downs; A Tsallios; A Holler; L Gao; V Wong; E Morris; H J Stauss
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

3.  RNAi-mediated TCR knockdown prevents autoimmunity in mice caused by mixed TCR dimers following TCR gene transfer.

Authors:  Mario Bunse; Gavin M Bendle; Carsten Linnemann; Laura Bies; Stephan Schulz; Ton N Schumacher; Wolfgang Uckert
Journal:  Mol Ther       Date:  2014-07-22       Impact factor: 11.454

4.  A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection.

Authors:  Emma C Morris; Aristotle Tsallios; Gavin M Bendle; Shao-An Xue; Hans J Stauss
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-20       Impact factor: 11.205

5.  CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2.

Authors:  Tomohisa Okamura; Keishi Fujio; Mihoko Shibuya; Shuji Sumitomo; Hirofumi Shoda; Shimon Sakaguchi; Kazuhiko Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

Review 6.  Molecular immunology lessons from therapeutic T-cell receptor gene transfer.

Authors:  Sharyn Thomas; Hans J Stauss; Emma C Morris
Journal:  Immunology       Date:  2010-02       Impact factor: 7.397

7.  Splenic phagocytes promote responses to nucleosomes in (NZB x NZW) F1 mice.

Authors:  Akiko Okamoto; Keishi Fujio; Nico van Rooijen; Nelson H Tsuno; Koki Takahashi; Hiromichi Tsurui; Sachiko Hirose; Keith B Elkon; Kazuhiko Yamamoto
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

8.  Dissection of the role of MHC class II A and E genes in autoimmune susceptibility in murine lupus models with intragenic recombination.

Authors:  Danqing Zhang; Keishi Fujio; Yi Jiang; Jingyuan Zhao; Norihiro Tada; Katsuko Sudo; Hiromichi Tsurui; Kazuhiro Nakamura; Kazuhiko Yamamoto; Hiroyuki Nishimura; Toshikazu Shira; Sachiko Hirose
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-10       Impact factor: 11.205

Review 9.  Current translational and clinical practices in hematopoietic cell and gene therapy.

Authors:  David L Digiusto; Hans-Peter Kiem
Journal:  Cytotherapy       Date:  2012-08       Impact factor: 5.414

10.  Human MHC Class I-restricted high avidity CD4+ T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo.

Authors:  Shao-An Xue; Liquan Gao; Maryam Ahmadi; Sara Ghorashian; Rafael D Barros; Constandina Pospori; Angelika Holler; Graham Wright; Sharyn Thomas; Max Topp; Emma C Morris; Hans J Stauss
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.